The International Market Analysis Research and Consulting Group (IMARC Group) has been keeping the top position in terms of provision consultancy services on management strategy and market for above 5 years.
IMARC Group serves customers from diverse industry areas in various regions of the globe by identifying their premium-value biz opps, dealing with their most burning issues, and converting their businesses. The company bears its clients a hand in improving decision-making and strategy-planning processes as well as in moving their business to a higher level.
The reports published by IMARC offer precise information on a slew of industries such as pharmaceutical, high-technology, advanced materials, food and beverage, biotechnology, nanotechnology, tourism and travel and a far more. The reports include detailed market analyses, overviews and forecasts, reviews of the economic and technological developments, profiles of the dominant companies, market/product assessments, etc. IMARC’s research approach unites deep insight into the market dynamics together with strong cooperation with each level of the client organization.
Publications found:
9,055
Sort by:
Primary Biliary Cholangitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major primary biliary cholangitis markets reached a value of US$ 510 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,200 Million by 2034, exhibiting a growth rate (C...
May 2024
136 pages
Progressive Pulmonary Fibrosis (PPF) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The progressive pulmonary fibrosis (PPF) market has been comprehensively analyzed in IMARC's new report titled 'Progressive Pulmonary Fibrosis (PPF) Market: Epidemiology, Industry Trends, Share, Size,...
May 2024
134 pages
Proteus Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The proteus syndrome market reached a value of US$ 1.2 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1.8 Billion by 2034,...
May 2024
132 pages
Psoriasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The psoriasis market reached a value of US$ 19.2 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the top 7 markets to reach US$ 35.8 Billion by...
May 2024
133 pages
Ptosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major ptosis markets reached a value of US$ 770.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,306.2 Million by 2034, exhibiting a growth rate (CAGR) of 4.92% dur...
May 2024
136 pages
Retinal Vein Occlusion Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major retinal vein occlusion markets reached a value of US$ 2,656.7 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4,919.5 Million by 2034, exhibiting a growth rate (...
May 2024
132 pages
